No Data
No Data
Pulse Biosciences' CellFX Nanosecond Pulsed Field Ablation (NsPFA) Technology to Be Featured in Several Presentations at The Heart Rhythm Society 2024 Annual Meeting
HAYWARD, Calif.--(BUSINESS WIRE)--May 16, 2024-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology, toda
Pulse Biosciences Names a New CEO With Former Boss Moving to CCO Role
Pulse Biosciences Welcomes New President and CEO Barrett
Pulse Biosciences: Danahy Will Now Lead the Pilot Launch of the Recently FDA Cleared CellFX NsPFA Percutaneous Electrode System
Pulse Biosciences: Danahy Will Now Lead the Pilot Launch of the Recently FDA Cleared CellFX NsPFA Percutaneous Electrode System
Pulse Biosciences Names Burke T. Barrett as President and CEO >PLSE
Pulse Biosciences Names Burke T. Barrett as President and CEO >PLSE
Pulse Biosciences Enhances Executive Leadership Team
Appoints proven atrial fibrillation medical technology leader Burke T. Barrettas President and Chief Executive Officer Former President and Chief Executive Officer Kevin Danahy appointed as Chief Comm